Inventiva reviewing options

 

• Inventiva is actively reviewing potential financing and discussing strategic options with its financial advisors and potential counterparties, including its major shareholders and potential new investors.
• On July 18, 2024, Inventiva issued royalty certificates subscribed by Samsara BioCapital and existing shareholders (BVF Partners, NEA, Sofinnova and Yiheng) for an amount of €20.1 million.
• Cash runway extended until mid-October 20243, following the issuance of the royalty certificates announced on July 18, 2024, and the implementation of cash preservation measures.

https://www.globenewswire.com/news-release/2024/09/25/2953320/0/en/Inventiva-provides-a-corporate-update-and-reports-its-unaudited-2024-first-half-financial-results.html